Thorax, Vol 52, 1051-1055, Copyright © 1997 by Thorax.

Decreased nitric oxide in the exhaled air of patients with systemic sclerosis with pulmonary hypertension

SA Kharitonov, JB Cailes, CM Black, RM du Bois and PJ Barnes
Department of Thoracic Medicine, National Heart and Lung Institute, Imperial School of Medicine, Royal Brompton Hospital, London, UK.

BACKGROUND: Systemic sclerosis (SSc) may be complicated by pulmonary hypertension (PHT), which can occur both in the setting of fibrosing alveolitis or as lone pulmonary vascular disease. Nitric oxide (NO) is a powerful vasodilator and is produced by various cells in the respiratory tract including pulmonary vascular endothelial cells and can be measured in expired air. A study was undertaken to test the hypothesis that exhaled NO levels would be decreased in patients with SSc with PHT and to assess the utility of this measurement in discriminating between patients with and without PHT, regardless of concurrent fibrosing alveolitis. METHODS: Exhaled NO was measured with a chemiluminescence analyser in 23 patients with SSc (six with PHT, 17 subjects without) and in 67 normal individuals. Doppler echocardiography was used to assess pulmonary artery pressure in subjects with SSc, and lung function tests were performed at the same visit as NO measurements. Thin section CT scans were analysed for the presence of abnormality consistent with fibrosing alveolitis. RESULTS: Patients with SSc with PHT had a greater reduction in arterial oxygen tension (PaO2) and carbon monoxide gas transfer (TLCO) than patients with SSc without PHT. Exhaled NO was significantly higher in patients with SSc without PHT than in normal individuals, and was significantly decreased in patients with SSc with PHT (mean (SD) 20 (6) ppb) compared with 149 (19) ppb in those with SSc without PHT (mean difference 129 (95% CI 112 to 146) ppb) and 80 (7) ppb in normal individuals (mean difference 60 (95% CI 54 to 66) ppb). CONCLUSION: Exhaled NO is decreased in patients with SSc with PHT compared with both normal individuals and patients with SSc without PHT.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Weerackody, R. P., Welsh, D. J., Wadsworth, R. M., Peacock, A. J. (2009). Inhibition of p38 MAPK reverses hypoxia-induced pulmonary artery endothelial dysfunction. Am. J. Physiol. Heart Circ. Physiol. 296: H1312-H1320 [Abstract] [Full Text]  
• Dimitroulas, T., Giannakoulas, G., Sfetsios, T., Karvounis, H., Dimitroula, H., Koliakos, G., Settas, L. (2008). Asymmetrical dimethylarginine in systemic sclerosis-related pulmonary arterial hypertension. Rheumatology (Oxford) 47: 1682-1685 [Abstract] [Full Text]  
• Malerba, M., Radaeli, A., Ragnoli, B., Airo', P., Corradi, M., Ponticiello, A., Zambruni, A., Grassi, V. (2007). Exhaled Nitric Oxide Levels in Systemic Sclerosis With and Without Pulmonary Involvement. Chest 132: 575-580 [Abstract] [Full Text]  
• Tiev, K. P., Cabane, J., Aubourg, F., Kettaneh, A., Ziani, M., Mouthon, L., Duong-Quy, S., Fajac, I., Guillevin, L., Dinh-Xuan, A. T. (2007). Severity of scleroderma lung disease is related to alveolar concentration of nitric oxide. Eur Respir J 30: 26-30 [Abstract] [Full Text]  
• Taylor, D R, Pijnenburg, M W, Smith, A D, Jongste, J C D (2006). Exhaled nitric oxide measurements: clinical application and interpretation. Thorax 61: 817-827 [Abstract] [Full Text]  
• Deja, M., Busch, T., Bachmann, S., Riskowski, K., Campean, V., Wiedmann, B., Schwabe, M., Hell, B., Pfeilschifter, J., Falke, K. J., Lewandowski, K. (2003). Reduced Nitric Oxide in Sinus Epithelium of Patients with Radiologic Maxillary Sinusitis and Sepsis. Am. J. Respir. Crit. Care Med. 168: 281-286 [Abstract] [Full Text]  
• Barbera, J.A., Peinado, V.I., Santos, S. (2003). Pulmonary hypertension in chronic obstructive pulmonary disease. Eur Respir J 21: 892-905 [Abstract] [Full Text]  
• Mehta, S. (2003). Sildenafil for Pulmonary Arterial Hypertension: Exciting, But Protection Required. Chest 123: 989-992 [Full Text]  
• Jinnin, M., Ihn, H., Yamane, K., Asano, Y., Yazawa, N., Tamaki, K. (2003). Plasma plasmin-{alpha}2-plasmin inhibitor complex levels are increased in systemic sclerosis patients with pulmonary hypertension. Rheumatology (Oxford) 42: 240-243 [Abstract] [Full Text]  
• Wodehouse, T., Kharitonov, S.A., Mackay, I.S., Barnes, P.J., Wilson, R., Cole, P.J. (2003). Nasal nitric oxide measurements for the screening of primary ciliary dyskinesia. Eur Respir J 21: 43-47 [Abstract] [Full Text]  
• Matucci Cerinic, M., Kahaleh, M. B. (2002). Beauty and the Beast. The nitric oxide paradox in systemic sclerosis. Rheumatology (Oxford) 41: 843-847 [Full Text]  
• Girgis, R. E., Gugnani, M. K., Abrams, J., Mayes, M. D. (2002). Partitioning of Alveolar and Conducting Airway Nitric Oxide in Scleroderma Lung Disease. Am. J. Respir. Crit. Care Med. 165: 1587-1591 [Abstract] [Full Text]  
• SULLIVAN, K. J., KISSOON, N., DUCKWORTH, L. J., SANDLER, E., FREEMAN, B., BAYNE, E., SYLVESTER, J. E., LIMA, J. J. (2001). Low Exhaled Nitric Oxide and a Polymorphism in the NOS I Gene Is Associated with Acute Chest Syndrome. Am. J. Respir. Crit. Care Med. 164: 2186-2190 [Abstract] [Full Text]  
• Cella, G., Bellotto, F., Tona, F., Sbarai, A., Mazzaro, G., Motta, G., Fareed, J. (2001). Plasma Markers of Endothelial Dysfunction in Pulmonary Hypertension. Chest 120: 1226-1230 [Abstract] [Full Text]  
• KHARITONOV, S. A., BARNES, P. J. (2001). Exhaled Markers of Pulmonary Disease. Am. J. Respir. Crit. Care Med. 163: 1693-1722 [Full Text]  
• Moodley, Y. P., Lalloo, U. G. (2001). Exhaled Nitric Oxide Is Elevated in Patients With Progressive Systemic Sclerosis Without Interstitial Lung Disease. Chest 119: 1449-1454 [Abstract] [Full Text]  
• Golbasl, Z., Dincer, S., Bayol, H., Ugurlu, B., Cicek, D., Keles, T., Aydogdu, S., Erbas, D. (2001). Increased nitric oxide in exhaled air in patients with rheumatic heart disease. Eur J Heart Fail 3: 27-32 [Abstract] [Full Text]  
• Yamane, K., Ihn, H., Asano, Y., Yazawa, N., Kubo, M., Kikuchi, K., Soma, Y., Tamaki, K. (2000). Clinical and laboratory features of scleroderma patients with pulmonary hypertension. Rheumatology (Oxford) 39: 1269-1271 [Abstract] [Full Text]  
• Romero, L. I, Zhang, D.-N., Cooke, J. P, Ho, H.-K. V, Avalos, E., Herrera, R., Herron, G S. (2000). Differential expression of nitric oxide by dermal microvascular endothelial cells from patients with scleroderma. Vasc Med 5: 147-158 [Abstract]  
• CLINI, E., CREMONA, G., CAMPANA, M., SCOTTI, C., PAGANI, M., BIANCHI, L., GIORDANO, A., AMBROSINO, N. (2000). Production of Endogenous Nitric Oxide in Chronic Obstructive Pulmonary Disease and Patients with Cor Pulmonale . Correlates with Echo-Doppler Assessment. Am. J. Respir. Crit. Care Med. 162: 446-450 [Abstract] [Full Text]  
• DUPLAIN, H., SARTORI, C., LEPORI, M., EGLI, M., ALLEMANN, Y., NICOD, P., SCHERRER, U. (2000). Exhaled Nitric Oxide in High-Altitude Pulmonary Edema . Role in the Regulation of Pulmonary Vascular Tone and Evidence for a Role against Inflammation. Am. J. Respir. Crit. Care Med. 162: 221-224 [Abstract] [Full Text]  
• Pearl, J. M., Nelson, D. P., Wellmann, S. A., Raake, J. L., Wagner, C. J., McNamara, J. L., Duffy, J. Y. (2000). Acute hypoxia and reoxygenation impairs exhaled nitric oxide release and pulmonary mechanics. J. Thorac. Cardiovasc. Surg. 119: 931-938 [Abstract] [Full Text]  
• Clini, E., Bianchi, L., Vitacca, M., Porta, R., Foglio, K., Ambrosino, N. (2000). Exhaled Nitric Oxide and Exercise in Stable COPD Patients. Chest 117: 702-707 [Abstract] [Full Text]  
• Peacock, A J (1999). Rare diseases bullet 5: Primary pulmonary hypertension. Thorax 54: 1107-1118 [Full Text]  
• Paredi, P., Kharitonov, S. A., Loukides, S., Pantelidis, P., Bois, R. M. d., Barnes, P. J. (1999). Exhaled Nitric Oxide Is Increased in Active Fibrosing Alveolitis. Chest 115: 1352-1356 [Abstract] [Full Text]